Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Skysona™ (elivaldogene autotemcel) – FDA drug safety communication
November 27, 2024 - The FDA announced it is investigating reports of hematologic malignancies associated with the use of Skysona (elivaldogene autotemcel).
